Clinical Trials Logo

Facial Wrinkles clinical trials

View clinical trials related to Facial Wrinkles.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT06322875 Not yet recruiting - Facial Wrinkles Clinical Trials

A Clinical Study to Evaluate the Efficacy and Satisfaction of RHC Serum Combined With RHC(III) Injection

Start date: March 2024
Phase: N/A
Study type: Interventional

To evaluate the efficacy and safety of recombinant humanized collagen (type III) solution for injection combined with SkinCeuticals recombinant humanized collagen (RHC) serum Participants will be assessed by subjective questionnaire (FACE-Q Satisfaction with skin,Global Aesthetic Improvement Scale, et al) and some medical instruments (VISIA,Ultrascan UC22 et al)

NCT ID: NCT03836638 Not yet recruiting - Aging Clinical Trials

The Impact of Age on Botulinum Toxin Potency in Facial Rhytides Treatment

Start date: May 1, 2019
Phase: N/A
Study type: Interventional

Botulinum toxin is approved by the FDA for the treatment of facial wrinkles. Patients are usually older than 45 years and their main demand is to treat pre-existing facial wrinkles. However with the increasing popularity of this technique, younger patients, aged 25 to 35 years, are now seeking botulinum toxin injection as a preventive measure for rhytides. The usual dose used for the treatment of facial rhytides in a female patient older than 45 years is 50 units. No consensus exists concerning the dose of botulinum toxin that should be used in younger patients. Hypothesis: lower dose of botulinum toxin is sufficient to give good and long lasting results in young patients. The objective of this randomized open-label study is to evaluate the effect of lower doses of Botulinum toxin on the facial rythides in young patients.